Beam Therapeutics
BEAM
#4017
Rank
NZ$5.23 B
Marketcap
NZ$51.39
Share price
10.03%
Change (1 day)
76.44%
Change (1 year)

Market capitalization of Beam Therapeutics (BEAM)

Market cap: NZ$5.23 Billion

As of April 2026 Beam Therapeutics has a market cap of NZ$5.23 Billion. This makes Beam Therapeutics the world's 4017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Beam Therapeutics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.23 B6.78%
2025NZ$4.90 B25.57%
2024NZ$3.90 B11.29%
2023NZ$3.50 B-19.18%
2022NZ$4.34 B-45.39%
2021NZ$7.94 B21.2%
2020NZ$6.55 B

End of Day market cap according to different sources

On Apr 12th, 2026 the market cap of Beam Therapeutics was reported to be:

NZ$4.75 Billion
by Nasdaq info icon info icon
NZ$4.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.98 B-62.11%๐Ÿ‡บ๐Ÿ‡ธ USA